
Please try another search
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Bart Meyns | - | 2023 | Member of Medical Advisory Board |
Stuart Bruce McConchie | 72 | 2023 | Independent Director |
Robert D. Dowling | - | - | Member of Medical Advisory Board |
Henrik Casimir Ahn | - | - | Member of Medical Advisory Board |
Zoltan Szabo | - | - | Member of Medical Advisory Board |
Giovanni Lauricella | - | 2023 | Independent Director |
Mia Tomczak | 57 | 2025 | Director |
Oliver Voigt | 52 | 2022 | Independent Director |
Oskar Mellgren | - | 2025 | Chairman of Board |
Azad Najar | 57 | 2008 | Founder, Chief Innovation Officer, Head of Product Development & Innovation and Director |
Ulf Kjellman | - | 2023 | Chief Medical Officer & Member of Medical Advisory Board |
Magnus Ohman | 64 | 2023 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review